Clinical Trials
All Clinical Trials - Page 12 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06619015Phase 2/Phase 3Withdrawn
Tailoring Obesity Treatment Trial
Semaglutide
- NCT06966687N/AEnrolling By Invitation
Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
Thymosin-Alpha-1
- NCT06838520N/ANot Yet Recruiting
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
Gonadorelin
- NCT06951854Phase 2Recruiting
Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder
Petrelintide
- NCT07244003Phase 4Recruiting
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Liraglutide
- NCT06897475Phase 2Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Tirzepatide
- NCT06721507Phase 4Recruiting
2024 Tirzepatide-Bariatric Surgery
Tirzepatide
- NCT06745284Phase 1Active Not Recruiting
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
Semaglutide
- NCT06862908Phase 2Active Not Recruiting
A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
Mazdutide
- NCT06890611Phase 1Completed
A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants
Tirzepatide
- NCT07163624Phase 2Completed
UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study
Semaglutide
- NCT06937060Phase 3Recruiting
Effect of Semaglutide in Patients With Psoriasis and Obesity
Semaglutide
- NCT06857942Phase 4Recruiting
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Tirzepatide
- NCT06893211Phase 2Completed
Effect of Tirzepatide on Brown Adipose Tissue in Obesity
Tirzepatide
- NCT06348134Phase 2Recruiting
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Ghrp-6
- NCT06291064Phase 2Recruiting
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Gonadorelin
- NCT07104487Phase 2Recruiting
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
Octreotide
- NCT06858878Phase 3Active Not Recruiting
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Maridebart-Cafraglutide
- NCT06856291N/ACompleted
Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
Semaglutide
- NCT07428525Phase 1Completed
A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Function
Maridebart-Cafraglutide
- NCT05829460Phase 2Withdrawn
Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
Semaglutide
- NCT06858839Phase 3Active Not Recruiting
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Maridebart-Cafraglutide
- NCT07429045Phase 1Completed
A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the Body
Maridebart-Cafraglutide
- NCT06883851N/ARecruiting
Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT06734273EARLY_Phase 1Active Not Recruiting
Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
Tirzepatide
- NCT06326190Phase 2Recruiting
177Lu-DOTATATE for Recurrent Meningioma
Octreotide
- NCT06582875Phase 2Recruiting
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
Tirzepatide
- NCT06864026Phase 4Active Not Recruiting
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Tirzepatide
- NCT06859268Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
Retatrutide
- NCT06774079Phase 4Recruiting
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
Tirzepatide
- NCT06772597Phase 2Active Not Recruiting
A Study of Setmelanotide in Patients With Prader-Willi Syndrome
Setmelanotide
- NCT06854614Phase 4Active Not Recruiting
Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
Tirzepatide
- NCT05646199Phase 2/Phase 3Unknown
Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
Semaglutide
- NCT06856928N/ANot Yet Recruiting
Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.
Tirzepatide
- NCT06855589Phase 3Not Yet Recruiting
Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.
Gonadorelin
- NCT06830343Phase 1Recruiting
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
Semaglutide
- NCT06513962Phase 3Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Gonadorelin
- NCT06804603Phase 2Completed
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
Semaglutide
- NCT06737042Phase 2Completed
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
Tirzepatide
- NCT06814938Phase 4Active Not Recruiting
A Study of a Novel Precision Medicine Approach For Obesity
Semaglutide
- NCT07223242Phase 2/Phase 3Recruiting
Tailored Exercise Training Study Among Adults With HFpEF
Tirzepatide
- NCT06715514N/AActive Not Recruiting
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Overweight/Obesity and Impaired Glucose Homeostasis
Semaglutide
- NCT06824051Phase 1Completed
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
Orforglipron
- NCT06630585Phase 3Recruiting
GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
Tirzepatide
- NCT07819227Phase 2Completed
Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide
Semaglutide
- NCT06829355Phase 2Recruiting
"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"
Thymosin-Alpha-1
- NCT06780449Phase 3Active Not Recruiting
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
Semaglutide
- NCT06772532Phase 1Completed
A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
Survodutide
- NCT06820476Phase 1Completed
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing
Amycretin
- NCT06817356Phase 2Completed
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Mazdutide